Lacasta María Antonia, Cruzado Juan Antonio
Clinical Psychologist, Palliative Care Unit and Hospital Support Team, La Paz University Hospital, Madrid, Spain.
Faculty of Psychology, Complutense University of Madrid, Ciudad Universitaria, Campus Somosaguas, Madrid, Spain.
Palliat Support Care. 2024 Oct;22(5):954-960. doi: 10.1017/S147895152300010X.
Complicated grief can affect a large number of individuals who have lost a relative due to cancer.
To assess the efficacy of a cognitive-behavioral grief therapy (CBGT) group for complicated grief (CG) in those who have lost a relative due to cancer in comparison with a psychoeducational and emotional expression intervention group (PSDEEI).
A randomized clinical trial was used, in which 249 relatives of deceased cancer patients with CG were randomly assigned to CBGT or PSDEEI. Complicated grief (Inventory of Complicated Grief [ICG]), depression (Beck Depression Inventory [BDI-II]), hopelessness (Beck Hopelessness Scale [BHS]), anxiety (Beck Anxiety Inventory [BAI]) symptoms, and general health (Goldberg's General Health Questionnaire [GHQ28]) were assessed at pretreatment, posttreatment, and follow-up at 6 and 12 months.
The CBGT group improved significantly ( < 0.001), with the scores in ICG, BDI-II, BAI, BHS, and GHQ28 ( < 0.001) being higher than those for the PSDEEI group in each of the assessed moments, with high effect sizes: ICG ( = 0.16), BDI ( = 0.10), BAI ( = 0.06), BHS ( = 0.21), and GHQ28 ( = 0.21). At the 12-month follow-up, the number of cases of CG decreased by 81.1% for the CBGT group vs. 31.7% in the PSDEEI group.
The CBGT treatment was effective for CG, depression, anxiety, and hopelessness symptoms and for mental health and was superior to the PSDEEI treatment.
复杂性悲伤会影响大量因癌症失去亲人的个体。
评估认知行为悲伤疗法(CBGT)组对因癌症失去亲人的复杂性悲伤(CG)患者的疗效,并与心理教育和情感表达干预组(PSDEEI)进行比较。
采用随机临床试验,将249名患有复杂性悲伤的已故癌症患者的亲属随机分配到CBGT组或PSDEEI组。在治疗前、治疗后以及6个月和12个月的随访时,评估复杂性悲伤(复杂性悲伤量表[ICG])、抑郁(贝克抑郁量表[BDI-II])、绝望感(贝克绝望量表[BHS])、焦虑(贝克焦虑量表[BAI])症状以及总体健康状况(戈德堡一般健康问卷[GHQ28])。
CBGT组有显著改善(<0.001),在每个评估时间点,ICG、BDI-II、BAI、BHS和GHQ28的得分(<0.001)均高于PSDEEI组,效应量较高:ICG(=0.16)、BDI(=0.10)、BAI(=0.06)、BHS(=0.21)和GHQ28(=0.21)。在12个月的随访中,CBGT组复杂性悲伤病例数减少了81.1%,而PSDEEI组为31.7%。
CBGT治疗对复杂性悲伤、抑郁、焦虑和绝望症状以及心理健康有效,且优于PSDEEI治疗。